Procter & Gamble (NYSE:PG) Price Target Lowered to $181.00 at JPMorgan Chase & Co.

Procter & Gamble (NYSE:PG) had its target price reduced by JPMorgan Chase & Co. from $186.00 to $181.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts also recently issued research reports about the company. Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Evercore ISI boosted their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. DA Davidson reaffirmed a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Friday, December 27th. Wells Fargo & Company cut their price objective on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.65.

Procter & Gamble Stock Up 0.5 %

PG opened at $161.35 on Thursday. Procter & Gamble has a one year low of $146.28 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock’s fifty day moving average is $169.19 and its 200-day moving average is $169.38. The company has a market capitalization of $379.98 billion, a PE ratio of 27.82, a P/E/G ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.83 EPS. On average, equities analysts predict that Procter & Gamble will post 6.93 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock worth $13,317,460 in the last three months. Insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

Several hedge funds have recently added to or reduced their stakes in the business. Acorn Creek Capital LLC increased its holdings in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. lifted its stake in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Traveka Wealth LLC lifted its stake in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after purchasing an additional 60 shares during the last quarter. Allen Mooney & Barnes Investment Advisors LLC lifted its stake in Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock valued at $1,507,000 after purchasing an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC lifted its position in Procter & Gamble by 11.2% during the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after acquiring an additional 61 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.